Wellspring Financial Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Wellspring Financial Advisors's EW Position: Q3 2026 in Review
Wellspring Financial Advisors increased its Edwards Lifesciences (EW) stake by 1.3% in Q3 2026, buying an estimated $2.93K and bringing the position to 2,523 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #245.
Wellspring Financial Advisors first reported a position in EW in Q4 2021 and has held it in 4 quarters since. The position peaked at $225K in Q2 2026. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Wellspring Financial Advisors held 2,523 shares of Edwards Lifesciences worth $218K as of Q3 2026.
- Wellspring Financial Advisors bought 33 Edwards Lifesciences shares in Q3 2026, an estimated $2.93K.
- Edwards Lifesciences made up 0.01% of Wellspring Financial Advisors's portfolio in Q3 2026, its #245 holding.
- Wellspring Financial Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 4 quarters since.
- Wellspring Financial Advisors's Edwards Lifesciences position peaked at $225K in Q2 2026.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Wellspring Financial Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.